[EN] HETEROCYCLIC DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUESEN TANT QU'ANTAGONISTES DU RÉCEPTEUR P2X7
申请人:AXXAM SPA
公开号:WO2022129365A1
公开(公告)日:2022-06-23
The present invention relates to novel 1,4-substituted piperidine compounds of formula (I) having P2X7 receptor (P2X7) antagonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment or prophylaxis of diseases associated with P2X7 receptor activity in animals, in particular humans.
本发明涉及一种具有P2X7受体(P2X7)拮抗作用的新型1,4-取代哌啶化合物(I)的制备方法,以及包含这些化合物的药物组合物,化学过程和它们在治疗或预防与P2X7受体活性相关的动物疾病,特别是人类疾病中的应用。